España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Compass Pathways
CMPS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Compass Pathways (CMPS) Forecast
News
Earnings
Compass Pathways (CMPS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Compass Pathways (NASDAQ:CMPS) Stock
Compass Pathways Stock (NASDAQ: CMPS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Thursday, November 14, 2024
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Franca Quarneti
Wednesday, November 13, 2024
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
Juan Spínelli
Tuesday, November 05, 2024
Top 3 Health Care Stocks You'll Regret Missing In November
Avi Kapoor
Friday, November 01, 2024
HC Wainwright & Co. Maintains Buy on Compass ...
Benzinga Newsdesk
Maxim Group Maintains Buy on Compass Pathways...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Compass P...
Benzinga Newsdesk
Thursday, October 31, 2024
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
Avi Kapoor
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Juan Spínelli
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
Avi Kapoor
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Compass Pathways shares are trading lower aft...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Compass Pathways Pushed Topline Data Readout ...
Benzinga Newsdesk
Compass Pathways Q3 2024 GAAP EPS $(0.56), In...
Benzinga Newsdesk
Wednesday, October 30, 2024
Uncovering Potential: Compass Pathways's Earnings Preview
Benzinga Insights
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, October 07, 2024
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
Juan Spínelli
Thursday, September 26, 2024
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
Juan Spínelli
Monday, September 23, 2024
'DEA Calls For Massive Increases In Psilocybi...
Benzinga Newsdesk
Friday, September 13, 2024
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Juan Spínelli
Tuesday, September 10, 2024
RBC Capital Reiterates Outperform on Compass ...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Thursday, September 05, 2024
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Franca Quarneti
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Juan Spínelli
Monday, August 26, 2024
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Friday, August 23, 2024
HC Wainwright & Co. Reiterates Buy on Compass...
Benzinga Newsdesk
Friday, August 02, 2024
Canaccord Genuity Maintains Buy on Compass Pa...
Benzinga Newsdesk
Thursday, August 01, 2024
Compass Pathways shares are trading lower aft...
Benzinga Newsdesk
Compass Pathways Q2 2024 GAAP EPS $(0.56) Mis...
Benzinga Newsdesk
Wednesday, July 31, 2024
HC Wainwright & Co. Reiterates Buy on Compass...
Benzinga Newsdesk
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Javier Hasse
Tuesday, July 23, 2024
RBC Capital Initiates Coverage On Compass Pat...
Benzinga Newsdesk
Tuesday, July 16, 2024
'MDMA Therapy Gets Support From Prominent Res...
Benzinga Newsdesk
Friday, June 21, 2024
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Wednesday, June 12, 2024
'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk
Wednesday, June 05, 2024
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
What's Going On With MindMed And Psychedelic Stocks?
Erica Kollmann
Shares of psychedelics companies are trading ...
Benzinga Newsdesk
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, June 03, 2024
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Friday, May 24, 2024
'Top Federal Drug Official Says There's 'Trem...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on Compass...
Benzinga Newsdesk
Thursday, May 09, 2024
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
Nina Zdinjak
Wednesday, May 08, 2024
Compass Pathways Reports Q1 Cash And Cash Equ...
Benzinga Newsdesk
Compass Pathways Q1 2024 GAAP EPS $(0.55) Mis...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch